Journal
Blood Advances
Publication Date
2020
Volume
4
Issue
11
First Page
2387
Last Page
2391
Document Type
Open Access Publication
DOI
10.1182/bloodadvances.2019000664
Rights and Permissions
Aabha Oza, Michael P. Rettig, Phil Powell, Kathryn O’Brien, David B. Clifford, Julie Ritchey, Leah Gehrs, Julia Hollaway, Eugene Major, Todd A. Fehniger, Christopher A. Miller, Patrick Soon-Shiong, Amy Rock, John F. DiPersio; Interleukin-15 superagonist (N-803) treatment of PML and JCV in a post–allogeneic hematopoietic stem cell transplant patient. Blood Adv 2020; 4 (11): 2387–2391. doi: https://doi.org/10.1182/bloodadvances.2019000664
Recommended Citation
Oza, Aabha; Rettig, Michael P.; Powell, Phil; O'Brien, Kathryn; Clifford, David B.; Ritchey, Julie; Gehrs, Leah; Hollaway, Julia; Major, Eugene; Fehniger, Todd A.; Miller, Christopher A.; Soon-Shiong, Patrick; Rock, Amy; and DiPersio, John F., "Interleukin-15 superagonist (N-803) treatment of PML and JCV in a post–allogeneic hematopoietic stem cell transplant patient." Blood Advances. 4, 11. 2387 - 2391. (2020).
https://digitalcommons.wustl.edu/open_access_pubs/9452
